Last updated: October 31, 2022
Sponsor: University of Calgary
Overall Status: Active - Enrolling
Phase
N/A
Condition
Dementia
Treatment
N/AClinical Study ID
NCT05220761
REB 20-2149
Ages < 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Admitted to Alberta Children's Hospital or McMaster Children's Hospital PICU duringstudy enrollment period
- Anticipated length of stay in PICU >/=48 hours
- Substitute decision maker with the ability to provide informed consent
- Primary caregiver available for CAPD assessments,
- Primary caregiver is defined as the person primarily responsible for the care andupbringing of a child and could include: Parents, designated older sibling, fosterparents/guardians, or grandparents, who fulfill this definition. There may be morethan one primary caregiver for each child
- Translated CAPD and educational materials available in primary spoken language (French, Chinese, Italian or Spanish)
Exclusion
Exclusion Criteria: I. Anticipated discharge/transfer within 24 hours II. Family member unable to understandthe instructions for CAPD assessment
a. This will be identified by the research assistant in collaboration with the bedside care team. i.e. language/cognitive barrier III. Child in irreversible coma (i.e. persistentvegetative state, RASS -4/SBS -2 or less and not reversible)
Study Design
Total Participants: 235
Study Start date:
August 09, 2021
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Laurie A. Lee
Calgary, Alberta T2T 5T3
CanadaSite Not Available
McMaster Children's Hospital
Hamilton, Ontario
CanadaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.